Molecular neurobiologyAnimalsTriterpenesDisease ModelsAnimalalpha-Synuclein
Potential Therapeutic Effects of Astragaloside IV in Parkinson's Disease Models via Modulation of α-syn-γH2AX-STING-IFN-I Axis.
Rui Wang, Fengjiao Sun, Nan Wang, Fang Chen, Xianzhi Wang, Chen Li, Hongcai Wang
Published: 202510.1007/s12035-025-05377-4
Abstract
Finding a new drug to slow or reverse the progression of Parkinson's disease (PD) is a significant step forward. Astragaloside Ⅳ (AS-Ⅳ) has been shown to have neuroprotective and anti-inflammatory properties, but its therapeutic effects and mechanism…
Preview only. Read the full abstract at the source